Coronary heart disease patients experiencing sudden cardiac arrest complications, mortality rate is very high (> 90%). Now, with advances in technology can be done a primary percutaneous coronary intervention (primary PCI). Primary PCI is a technique to remove thrombus and widen the narrowed coronary arteries with balloon catheters and stent be done.
This action can eliminate the blockage with immediately, so that blood flow can be normal again, so the heart muscle damage can be avoided. Nowadays primary PCI is the best treatment of acute cardiac infarction, because it can stop an attack of acute heart infarction and reduce mortality to below 2%.
Choice of action in patients with coronary heart disease, is it enough just with medication and how when compared with revascularization? In most patients with stable coronary heart disease can be given medical treatment as an alternative to the PCI and the complications that occurred less than PCI or surgery in the follow-up for 1 year at MASS study.
From the ACIP study (The Asymptomatic Cardiac Ischaemia Pilot) obtained in patients with high risk of having a better outcome with revascularization.
From various studies (ACME, RITA-2 trial) stated that PCI ( Percutneous Coronary Intervention ) better in improving patient quality of life than medical drugs. In the AVERT study, 341 patients with coronary heart disease with medical treatment of atorvastatin 80 mg per day. From these results it was found that in patients with stable coronary heart disease and low risk, medical treatment including aggressive fat-lowering drugs may be as effective as PCI( Percutneous Coronary Intervention ) in terms of reduction in ischemic events. Angina symptoms is better controlled by the PCI ( Percutneous Coronary Intervention ).
It could be argued that the invasive action performed on patients with high risk or who are not well controlled with medical drugs, whereas pharmacotherapy alone in patients with high risk or who are not well controlled with medical drugs, whereas pharmacotherapy alone in patients with stable coronary heart disease with low risk
No comments:
Post a Comment